2[3]Hosenpud JD, Bennett LE, Keck BM, et al. The registry of the international society for heart and lung transplantation:sixteenth official report- 1999 [J]. J Heart Lung Transplantation, 1999, 18:611 - 626 被引量：1
3[4]Vincenti F, Kirkman R, Light S, et al. Interleukin - 2- receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Study Group[J]. N Engl J Med, 1998,338:161 - 165 被引量：1
4[6]Fleischer KJ, Baumgartner WA. Heart transplantation[M]. In: Henry Edmunds L. Cardiac Surgery in the Adult. NY: McGraw - Hill, 1997:1409 - 1449 被引量：1
5[7]Hakin M, Wallwork J, English T. Cyclosporine A in cardiac transplantation. Medium - result in 62 patients[J]. Ann Thorac Surg, 1998, 46: 495 - 501 被引量：1
6[8]Coopersmith CM, Brennan DC, Miller B, et al. Renal transplantation following previous heart, liver, and lung transplantation:an 8 - year single- center experience[J]. Surgery, 2001 被引量：1
7[9]H. Ekberg, L. Backman, G. Tufveson, et al. The study of Zenapax for acute rejection and the survival rate:one year analysis[J]. Transplant Int, 2000, 13:151 - 159 被引量：1
8[10]A.V. Reisaeter and A. Hartmann, Risk Factors and Incidence of Posttransplant Diabetes Mellitus [ J ]. Transplant Proc, 2001,33(5A) :8s - 10s 被引量：1
9[11]G. Viberti. Diabetes Mellitus: A Major Challenge in Transplantation[ J ]. Transplant Proc, 2001, 33 (5A):3s-6s 被引量：1
9Smith L,Farroni J,Baillie BR,et al.Heart transplantation on answer for end-stage heart failure[J].Crit Care Nurs Clin North Am,2003,15(4):489-494. 被引量：1
10Young JB,Naftel DC,Bourge RC,et al.Matching the heart donor and heart transplant recipient.Clues for successful expansion of the donor pool:A multivariable,multi-institutional report[J].J Heart Lung Transplant,1994,13(3):353-364. 被引量：1
